Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Splitting the dose or adding a second daily injection is not part of the clinical protocol and may not improve outcomes
small human dermatology studies report increases in collagen synthesis and reductions in wrinkle depth over 812 weeks. Phase 1: Activation (Weeks 14) Dose: 3.2 mg daily GHK-Cu activates collagen production while its copper component enables proper structural cross-linking BPC-157 builds the network of small blood vessels needed to feed active tissue TB-4 mobilizes and organizes repair cells KPV simultaneously suppresses inflammatory interference Expected: Skin hydration improves, tone evens, texture softens, redness decreases
As a triple agonist , it simultaneously activates three distinct receptor systems [5]: GIP (Glucose-dependent Insulinotropic Polypeptide) receptors enhance insulin secretion and may have direct effects on adipose tissue GLP-1 (Glucagon-like Peptide-1) receptors promote satiety, slow gastric emptying, and improve glucose regulation Glucagon receptors increase energy expenditure and may enhance fat oxidation This multi-receptor targeting strategy distinguishes retatrutide from single-pathway peptides and creates a complex metabolic profile that researchers are still working to fully characterize
S Seiwerth, et al
Studies in sebocytes show GHK suppresses IL-6 gene expression, contributing to reduced inflammatory signaling
Heres How GHK-Cu Supports Recovery and Longevity 1
